Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,034,236
-$63,364 QoQ
Shares Held
59,133
-28.7% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. BIOA ranks #23 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,014,966 | $270,402,187 | |
| 2 | ZTS |
Zoetis Inc.
|
1,610,634 | $190,393,043 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
512,033 | $67,455,225 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
91,225 | $54,094,599 | |
| 5 | ALKS |
Alkermes plc.
|
741,141 | $26,206,745 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,865,201 | $23,184,446 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
270,262 | $20,783,147 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
269,945 | $20,475,327 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,034,236 | 59,133 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,097,600 | 82,963 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $179,122 | 30,463 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $181,860 | 44,034 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||